These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34935876)

  • 1. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines.
    Sun Q; Freeman EE
    JAMA Dermatol; 2022 Feb; 158(2):217-218. PubMed ID: 34935876
    [No Abstract]   [Full Text] [Related]  

  • 2. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines-Reply.
    McCleskey PE; Lieberman A; Herrinton LJ
    JAMA Dermatol; 2022 Feb; 158(2):218-219. PubMed ID: 34935853
    [No Abstract]   [Full Text] [Related]  

  • 3. Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report.
    Souaid K; Oulès B; Sohier P; Deschamps L; Aractingi S; Dupin N
    Acta Derm Venereol; 2021 Nov; 101(11):adv00589. PubMed ID: 34396420
    [No Abstract]   [Full Text] [Related]  

  • 4. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
    De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M
    Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?
    Meara AS; Silkowski M; Quin K; Jarjour W
    J Rheumatol; 2021 Nov; 48(11):1754. PubMed ID: 34210829
    [No Abstract]   [Full Text] [Related]  

  • 6. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study.
    Poizeau F; Oger E; Barbarot S; Le Corre Y; Samimi M; Brenaut E; Aubert H; Chambrelan E; Droitcourt C; Gissot V; Heslan C; Laurent C; Martin L; Misery L; Tattevin P; Toubel A; Thibault V; Dupuy A
    Clin Microbiol Infect; 2022 Feb; 28(2):285-291. PubMed ID: 34619397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pernio after COVID-19 vaccination.
    Lopez S; Vakharia P; Vandergriff T; Freeman EE; Vasquez R
    Br J Dermatol; 2021 Aug; 185(2):445-447. PubMed ID: 33893637
    [No Abstract]   [Full Text] [Related]  

  • 8. Post SARS-CoV-2 Vaccine Chilblains-like Lesions.
    Mungmunpuntipantip R; Wiwanitkit V
    J Rheumatol; 2022 Jul; 49(7):859. PubMed ID: 35428717
    [No Abstract]   [Full Text] [Related]  

  • 9. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 10. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine.
    Cameli N; Silvestri M; Mariano M; Nisticò SP; Cristaudo A
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e725-e727. PubMed ID: 34236735
    [No Abstract]   [Full Text] [Related]  

  • 12. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmented interferon I signaling in a patient with COVID toes.
    Komura K; Ichimura Y; Okiyama N; Watanabe K; Muramoto H; Matsushita T
    J Dermatol; 2021 May; 48(5):e242-e243. PubMed ID: 33745200
    [No Abstract]   [Full Text] [Related]  

  • 14. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned. Reply from the authors.
    Colmenero I; Santonja C; Alonso-Riaño M; Andina D; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Dec; 183(6):1153-1154. PubMed ID: 32798316
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
    Bessis D
    Br J Dermatol; 2021 Jan; 184(1):11-12. PubMed ID: 33249567
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
    Bessis D; Trouillet-Assant S; Secco LP; Bardin N; Blanc B; Blatière V; Chable-Bessia C; Delfour C; Girard C; Richard JC; Gros N; Le Moing V; Molinari N; Pallure V; Pisoni A; Raison-Peyron N; Reynaud E; Schwob É; Pescarmona R; Samaran Q; Willems M; Vincent T; Sofonea MT; Belot A; Tuaillon É
    Br J Dermatol; 2022 Dec; 187(6):1032-1035. PubMed ID: 35971922
    [No Abstract]   [Full Text] [Related]  

  • 18. Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic".
    López-Sundh AE; Gómez-Fernández C; González-López MA
    J Cutan Med Surg; 2021; 25(3):342-343. PubMed ID: 33624512
    [No Abstract]   [Full Text] [Related]  

  • 19. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
    Temiz SA; Abdelmaksoud A; Dursun R; Vestita M
    Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629
    [No Abstract]   [Full Text] [Related]  

  • 20. Chilblains-like Nonischemic Eruption During the COVID-19 Pandemic-Distinct Features in Adolescents.
    Gorouhi F
    JAMA Netw Open; 2021 Jun; 4(6):e2111676. PubMed ID: 34110397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.